Leukotriene A4 Hydrolase as a Target for Cancer Prevention and Therapy
Journal:
Current Cancer Drug Targets
Volume:
4
Page:
267-283
Author(s):
X. Chen, S. Wang, N. Wu and C. S. Yang
ABC Transporters and the Blood-Brain Barrier
Journal:
Current Pharmaceutical Design
Volume:
10
Page:
1295-1312
Author(s):
David J. Begley
Drug Delivery Systems for Brain Tumor Therapy
Journal:
Current Pharmaceutical Design
Volume:
10
Page:
1341-1353
Author(s):
Jarkko Rautioa and Prashant J. Chikhale
Are the Extracelluar Pathways a Conduit for the Delivery of Therapeutics to the Brain?
Journal:
Current Pharmaceutical Design
Volume:
10
Page:
1365-1370
Author(s):
William A. Banks
Biochemical Aspects of Nitric Oxide
Journal:
Current Pharmaceutical Design
Volume:
10
Page:
1627-1645
Author(s):
Sofia Mariotto, Marta Menegazzi and Hisanori Suzuki
Recent Structure-Activity Studies of the Peptide Hormone Urotensin-II, a Potent Vasoconstrictor
Journal:
Current Medicinal Chemistry
Volume:
11
Page:
969-979
Author(s):
P. Grieco, P. Rovero and E. Novellino
Nonnucleoside Inhibitors of Adenosine Kinase
Journal:
Current Pharmaceutical Design
Volume:
10
Page:
1093-1103
Author(s):
Arthur Gomtsyan and Chih-Hung Lee
Endocannabinoids and their Involvement in the Neurovascular System
Journal:
Current Neurovascular Research
Volume:
1
Page:
129-140
Author(s):
Natalia Battista, Filomena Fezza and Mauro Maccarrone
Targeting the Chemokine Receptor CXCR3 and Its Ligand CXCL10 in the Central Nervous System: Potential Therapy for Inflammatory Demyelinating Disease?
Journal:
Current Neurovascular Research
Volume:
1
Page:
183-190
Author(s):
Torben Lykke Sørensen
Introduction: P2 Receptors
Journal:
Current Topics in Medicinal Chemistry
Volume:
4
Page:
793-803
Author(s):
Geoffrey Burnstock